These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 22195536)
41. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media. Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728 [TBL] [Abstract][Full Text] [Related]
42. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material. Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428 [TBL] [Abstract][Full Text] [Related]
43. Comparison of a low-osmolar contrast medium, iopamidol, and an iso-osmolar contrast medium, iodixanol, in MDCT coronary angiography. Ozbulbul NI; Yurdakul M; Tola M Coron Artery Dis; 2010 Nov; 21(7):414-9. PubMed ID: 20671550 [TBL] [Abstract][Full Text] [Related]
44. Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69,657 intravenous injections. Wang CL; Cohan RH; Ellis JH; Adusumilli S; Dunnick NR Radiology; 2007 Apr; 243(1):80-7. PubMed ID: 17392249 [TBL] [Abstract][Full Text] [Related]
45. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations. Häussler MD Acta Radiol; 2010 Oct; 51(8):924-33. PubMed ID: 20828300 [TBL] [Abstract][Full Text] [Related]
46. Safety of low volume iodinated contrast administration for arteriovenous fistula intervention in chronic kidney disease stage 4 or 5 utilizing a bicarbonate prophylaxis strategy. Eisenhart E; Benson S; Lacombe P; Himmelfarb J; Zimmerman R; Schimelman B; Parker MG Semin Dial; 2010; 23(6):638-42. PubMed ID: 21175838 [TBL] [Abstract][Full Text] [Related]
54. Cytokine profiles after nonionic dimeric contrast medium injection. Böhm I; Speck U; Schild H Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895 [TBL] [Abstract][Full Text] [Related]
55. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374 [TBL] [Abstract][Full Text] [Related]
56. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. McCullough PA; Bertrand ME; Brinker JA; Stacul F J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536 [TBL] [Abstract][Full Text] [Related]
57. [Experimental and clinical determination of renal size after intravenous and intra-arterial administration of ionic and non-ionic contrast media]. Helzel MV; Wolf GK; Prager P Rofo; 1985 Mar; 142(3):333-7. PubMed ID: 2984739 [TBL] [Abstract][Full Text] [Related]
58. Incidence of amiodarone hypersensitivity in patients with previous allergy to iodine or iodinated contrast agents. Lakshmanadoss U; Lindsley J; Glick D; Twilley CH; Lewin JJ; Marine JE Pharmacotherapy; 2012 Jul; 32(7):618-22. PubMed ID: 22605538 [TBL] [Abstract][Full Text] [Related]
59. [Clinical tolerability of ioversol 300 in brain computed tomography]. Gillard C; Tatu L; Menegazzo D; Bonneville JF Ann Radiol (Paris); 1992; 35(4 Pt 2):284-7. PubMed ID: 1296493 [TBL] [Abstract][Full Text] [Related]
60. Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy. Chamsuddin AA; Kowalik KJ; Bjarnason H; Dietz CA; Rosenberg MS; Gomes MD; McDermott CM; Hunter DW AJR Am J Roentgenol; 2002 Sep; 179(3):591-6. PubMed ID: 12185025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]